J Clin Med Res

Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access

Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc

Journal website http://www.jocmr.org

Original Article

Volume 1, Number 5, December 2009, pages 280-284

The Effects of Injection Site on the Reflux Following Intravitreal Injections

Figure

Figure 1. Box plot Graphics demonstrates the amount of reflux after the injection

Table

**Table 1.** The Reflux Amounts and the IOP Measurements After the Injection (Mean ± SD) in the Study Groups
Groups	Subconjunctival Bleb Diameters(Mean ± SD)	IOP Measurements
Groups	Subconjunctival Bleb Diameters(Mean ± SD)	(Mean ± SD)
IVTA: Intravitreal Triamcinolone; IVB: Intravitreal bevacizumab; IVP: Intravitreal pegaptanib.
Group 1 (IVTA-Superotemporal Injection)	3.20 ± 1.63 mm	17.6 ± 4.1 mm Hg
Group 2 (IVTA-Inferotemporal Injection)	1.50 ± 0.94 mm	19.0 ± 4.7 mm Hg
Group 3 (IVB-Superotemporal Injection)	3.07 ± 1.53 mm	15.3 ± 3.1 mm Hg
Group 4 (IVB-Inferotemporal Injection)	1.60 ± 1.07 mm	16.8 ± 3.5 mm Hg
Group 5 (IVP-Superotemporal Injection)	2.80 ± 1.32 mm	18.4 ± 4.4 mm Hg
Group 6 (IVP-Inferotemporal Injection)	1.77 ± 0.94 mm	20.1 ± 5.2 mm Hg
P value	P < 0.05 Group 1 vs. Group 2	P > 0.05 for all the groups
	P < 0.05 Group 3 vs. Group 4
	P < 0.05 Group 5 vs. Group 6